Adjuvant therapy for stages II and III colon cancer: risk stratification, treatment duration, and future directions von Bender, U, Rho, Y S, Barrera, I, Aghajanyan, S, Acoba, J, Kavan, P

Volltext

Quality of life in a real-world study of patients with metastatic colorectal cancer treated with trifluridine/tipiracil von Cheung, W Y, Kavan, P, Dolley, A

Volltext

Treatment algorithm in cancer-associated thrombosis: Canadian expert consensus von Carrier, M, Blais, N, Crowther, M, Kavan, P, Le Gal, G, Moodley, O, Shivakumar, S, Tagalakis, V, Wu, C, Lee, A Y Y

Volltext

A retrospective observational study to estimate the attrition of patients across lines of systemic treatment for metastatic colorectal cancer in Canada von Kennecke, H, Berry, S, Maroun, J, Kavan, P, Aucoin, N, Couture, F, Poulin-Costello, M, Gillesby, B

Volltext

A multi-institutional randomized phase II study on the timing of oxaliplatin plus 5-fluorouracil (FOLFOX) for patients (pts) with operable stage III rectal cancer: The KIR study von Kavan, P, Barrera, I, Azoulay, L, Martin, A-G, Vasilevsky, C, Boutros, M, Ferland, E, Batist, G, Vuong, T

Volltext

2359 Optimal therapeutic sequences in the treatment of metastatic pancreatic cancer - a retrospective analysis from two Canadian and French tertiary cancer centres von Gilabert, M, Rho, Y.S, Kavan, T, Chanez, B, Mamo, A, Barrera, I, McLean, J, Viens, P, Batist, G, Kavan, P

Volltext

Safety and antitumor activity of pembrolizumab in patients with advanced microsatellite instability–high (MSI-H) colorectal cancer: KEYNOTE-164 von Le, D., Kavan, P., Kim, T., Burge, M., Van Cutsem, E., Hara, H., Boland, P., Van Laethem, J., Geva, R., Taniguchi, H., Crocenzi, T., Sharma, M., Atreya, C., Diaz, L., Liang, L., Marinello, P., Dai, T., O’Neill, B.

Volltext

Retrospective analysis of the effect of CAPOX and mFOLFOX6 dose intensity on survival in colorectal patients in the adjuvant setting von Mamo, A, Easaw, J, Ibnshamsah, F, Baig, A, Rho, Y S, Kavan, T, Batist, G, Kavan, P

Volltext

2149 Impact of dose intensity in CAPOX and mFOLFOX6 in the treatment of metastatic colorectal cancer von Mamo, A, Rho, Y.S, Gao, Y.N, Kavan, T, McLean, J, Gilabert, M, Ivan, B, Batist, G, Chaudhury, P, Metrakos, P, Panasci, L, Kavan, P

Volltext

Copy number variation in longitudinal liver metastases biopsies in colorectal cancer identifies biomarker candidates of resistance to standard chemotherapy von Gambaro, K., Marques, M., McNamara, S., du Tertre, M. Couetoux, Hoffert, C., Srivastava, A., Samson, B., Lesperance, B., Ko, Y., Dalfen, R., St-Hilaire, E., Sideris, L., Couture, F., Burkes, R., Harb, M., Camlioglu, E., Gologan, A., Pelsser, V., Tejpar, S., Kavan, P., Kleinman, C., Batist, G.

Volltext

Canadian consensus recommendations on the management of venous thromboembolism in patients with cancer. Part 1: prophylaxis von Easaw, J C, Shea-Budgell, M A, Wu, C M J, Czaykowski, P M, Kassis, J, Kuehl, B, Lim, H J, MacNeil, M, Martinusen, D, McFarlane, P A, Meek, E, Moodley, O, Shivakumar, S, Tagalakis, V, Welch, S, Kavan, P

Volltext

Characterizations of DNA copy number variations and spatio-temporal intra tumor heterogeneity in liver metastasis from colorectal cancer patients von Marques, M., Gambaro, K., du Tertre, M. Couetoux, Witcher, M., Samson, B., Lesperance, B., Ko, Y., Dalfen, R., St-Hilaire, E., Sideris, L., Couture, F., Tejpar, S., Burkes, R., Harb, M., Alcindor, T., Camlioglu, E., Gologan, A., Pelsser, V., McNamara, S., Kavan, P., Kleinman, C., Batist, G.

Volltext

Canadian consensus recommendations on the management of venous thromboembolism in patients with cancer. Part 2: treatment von Easaw, J C, Shea-Budgell, M A, Wu, C M J, Czaykowski, P M, Kassis, J, Kuehl, B, Lim, H J, MacNeil, M, Martinusen, D, McFarlane, P A, Meek, E, Moodley, O, Shivakumar, S, Tagalakis, V, Welch, S, Kavan, P

Volltext

What is a clinically meaningful survival benefit in refractory metastatic colorectal cancer? von Ko, Y J, Abdelsalam, M, Kavan, P, Lim, H, Tang, P A, Vincent, M, Wong, R, Kish, M, Gill, S

Volltext

2354 Is pancreatic adenocarcinoma more aggressive in adolescents and young adults? A multi-institute retrospective study von Gilabert, M, Rho, Y.S, Megdanova, V, Mihaylova, Z, Rahal, S, Viens, P, Batist, G, Kavan, P

Volltext

Comparative net cost impact of the utilization of panitumumab versus cetuximab for the treatment of patients with metastatic colorectal cancer in Canada von Pettigrew, M., Kavan, P., Surprenant, L., Lim, H. J.

Volltext

Real-Life Report on Chemoembolization Using DEBIRI for Liver Metastases from Colorectal Cancer von Kavan, P., Garoufalis, E., Chaudhury, P., Metrakos, P., Cabrera, T., Hausvater, A., Valenti, D., Mamo, A., Stutz, M., Steacy, G.

Volltext

Functional Neuroanatomy of Secondary Self-Injurious Behavior von Peeters, Sophie, Skoch, Jesse, Holt, Hiromi, Mubita, Lynn, Choudhary, Eileen A., Vadivelu, Kavan P., Gilbert, Donald L., Wu, Steve W., Keebaugh, Alaine C., Air, Ellen, Vadivelu, Sudhakar

Volltext

Progression pattern and adverse events with bevacizumab in glioblastoma von Mamo, A, Baig, A, Azam, M, Rho, Y S, Sahebjam, S, Muanza, T, Owen, S, Petrecca, K, Guiot, M C, Al-Shami, J, Sharma, R, Kavan, P

Volltext

2054 Clinical outcomes of adolescent and young adult patients (AYAp) vs mature adult patients (MATp) with colorectal cancer (CRC), a multi-institutional retrospective review von Rho, Y.S, Gilabert, M, Barrera, I, Coleman, N, Greally, M, McDermott, R, Megdanova, V, Veneta, P, Zhasmina, M, Katerina, K, Bortlicek, Z, Pikus, T, Zdenek, L, Batist, G, Kavan, P

Volltext